-
1
-
-
84901349294
-
A worldwide trend of increasing primary adenocarcinoma of the lung
-
H. Nakamura, and H. Saji A worldwide trend of increasing primary adenocarcinoma of the lung Surg Today 44 2014 1004 1012
-
(2014)
Surg Today
, vol.44
, pp. 1004-1012
-
-
Nakamura, H.1
Saji, H.2
-
2
-
-
84877975654
-
Diagnosis of lung adenocarcinoma in resected specimens: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification
-
W.D. Travis, E. Brambilla, and M. Noguchi Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification Arch Pathol Lab Med 137 2013 685 705
-
(2013)
Arch Pathol Lab Med
, vol.137
, pp. 685-705
-
-
Travis, W.D.1
Brambilla, E.2
Noguchi, M.3
-
3
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
T. Lynch, D. Bell, and R. Sordella Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.1
Bell, D.2
Sordella, R.3
-
4
-
-
2342624080
-
EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
-
J. Paez, P. Janne, and J. Lee EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
-
(2004)
Science
, vol.304
, pp. 1497-1500
-
-
Paez, J.1
Janne, P.2
Lee, J.3
-
5
-
-
84859397680
-
Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis
-
Y. Zhang, Y. Sun, and Y. Pan Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis Clin Cancer Res 18 2012 1947 1953
-
(2012)
Clin Cancer Res
, vol.18
, pp. 1947-1953
-
-
Zhang, Y.1
Sun, Y.2
Pan, Y.3
-
6
-
-
84875235174
-
Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients - A single institution retrospective study of 292 lung adenocarcinoma
-
J. Gu, C. Lu, and J. Guo Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients - a single institution retrospective study of 292 lung adenocarcinoma J Surg Oncol 107 2013 474 480
-
(2013)
J Surg Oncol
, vol.107
, pp. 474-480
-
-
Gu, J.1
Lu, C.2
Guo, J.3
-
7
-
-
84879911109
-
Epidermal growth factor receptor mutation in lung adenocarcinomas: Relationship with CT characteristics and histologic subtypes
-
H.J. Lee, Y.T. Kim, and C.H. Kang Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes Radiology 268 2013 254 264
-
(2013)
Radiology
, vol.268
, pp. 254-264
-
-
Lee, H.J.1
Kim, Y.T.2
Kang, C.H.3
-
8
-
-
84871969337
-
Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: Analysis of 440 Japanese patients
-
A. Yoshizawa, S. Sumiyoshi, and M. Sonobe Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients J Thorac Oncol 8 2013 52 61
-
(2013)
J Thorac Oncol
, vol.8
, pp. 52-61
-
-
Yoshizawa, A.1
Sumiyoshi, S.2
Sonobe, M.3
-
9
-
-
84881662088
-
The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
-
K. Tsuta, M. Kawago, and E. Inoue The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations Lung Cancer 81 2013 371 376
-
(2013)
Lung Cancer
, vol.81
, pp. 371-376
-
-
Tsuta, K.1
Kawago, M.2
Inoue, E.3
-
10
-
-
69949186250
-
Screening for epidermal growth factor receptor mutations in lung cancer
-
R. Rosell, T. Moran, and C. Queralt Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 2009 958 967
-
(2009)
N Engl J Med
, vol.361
, pp. 958-967
-
-
Rosell, R.1
Moran, T.2
Queralt, C.3
-
11
-
-
84885191153
-
EGFR mutational status in a large series of Caucasian European NSCLC patients: Data from daily practice
-
S. Gahr, R. Stoehr, and E. Geissinger EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice Br J Cancer 109 2013 1821 1828
-
(2013)
Br J Cancer
, vol.109
, pp. 1821-1828
-
-
Gahr, S.1
Stoehr, R.2
Geissinger, E.3
-
12
-
-
34548457234
-
The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
-
P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
-
(2007)
J Thorac Oncol
, vol.2
, pp. 706-714
-
-
Goldstraw, P.1
Crowley, J.2
Chansky, K.3
-
13
-
-
80052264344
-
Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification
-
P.A. Russell, Z. Wainer, and G.M. Wright Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification J Thorac Oncol 6 2011 1496 1504
-
(2011)
J Thorac Oncol
, vol.6
, pp. 1496-1504
-
-
Russell, P.A.1
Wainer, Z.2
Wright, G.M.3
-
14
-
-
84885428606
-
Prognostic value of the IASLC/ATS/ERS classification in stage i lung adenocarcinoma patients - Based on a hospital study in China
-
Z. Song, H. Zhu, and Z. Guo Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients - based on a hospital study in China Eur J Surg Oncol 39 2013 1262 1268
-
(2013)
Eur J Surg Oncol
, vol.39
, pp. 1262-1268
-
-
Song, Z.1
Zhu, H.2
Guo, Z.3
-
15
-
-
23844465454
-
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp
-
Y. Nagai, H. Miyazawa, and Huqun Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp Cancer Res 65 2005 7276 7282
-
(2005)
Cancer Res
, vol.65
, pp. 7276-7282
-
-
Nagai, Y.1
Miyazawa, H.2
Huqun3
-
16
-
-
38949177364
-
Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation
-
H. Miyazawa, T. Tanaka, and Y. Nagai Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation Cancer Sci 99 2008 595 600
-
(2008)
Cancer Sci
, vol.99
, pp. 595-600
-
-
Miyazawa, H.1
Tanaka, T.2
Nagai, Y.3
-
17
-
-
0001621471
-
Note on an exact treatment of contingency, goodness of fit and other problems of significance
-
G. Freeman, and J. Halton Note on an exact treatment of contingency, goodness of fit and other problems of significance Biometrika 38 1951 141 149
-
(1951)
Biometrika
, vol.38
, pp. 141-149
-
-
Freeman, G.1
Halton, J.2
-
18
-
-
84888138347
-
Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage i lung adenocarcinoma
-
J.J. Hung, W.J. Jeng, and T.Y. Chou Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma Ann Surg 258 2013 1079 1086
-
(2013)
Ann Surg
, vol.258
, pp. 1079-1086
-
-
Hung, J.J.1
Jeng, W.J.2
Chou, T.Y.3
-
19
-
-
84907226113
-
The new histological classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: The experience of a French cohort
-
A. Mansuet-Lupo, A. Bobbio, and H. Blons The new histological classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort Chest 146 2014 633 643
-
(2014)
Chest
, vol.146
, pp. 633-643
-
-
Mansuet-Lupo, A.1
Bobbio, A.2
Blons, H.3
-
20
-
-
84860379332
-
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival
-
A. Warth, T. Muley, and M. Meister The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival J Clin Oncol 30 2012 1438 1446
-
(2012)
J Clin Oncol
, vol.30
, pp. 1438-1446
-
-
Warth, A.1
Muley, T.2
Meister, M.3
-
21
-
-
79955571953
-
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage i cases
-
A. Yoshizawa, N. Motoi, and G.J. Riely Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Mod Pathol 24 2011 653 664
-
(2011)
Mod Pathol
, vol.24
, pp. 653-664
-
-
Yoshizawa, A.1
Motoi, N.2
Riely, G.J.3
-
22
-
-
84867404458
-
Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification
-
A. Warth, J. Cortis, and L. Fink Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification Virchows Arch 461 2012 185 193
-
(2012)
Virchows Arch
, vol.461
, pp. 185-193
-
-
Warth, A.1
Cortis, J.2
Fink, L.3
-
23
-
-
84896685538
-
Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma
-
D.H. Hwang, D.P. Szeto, and A.S. Perry Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma Arch Pathol Lab Med 138 2014 626 635
-
(2014)
Arch Pathol Lab Med
, vol.138
, pp. 626-635
-
-
Hwang, D.H.1
Szeto, D.P.2
Perry, A.S.3
-
24
-
-
84875405224
-
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients
-
P.A. Russell, S.A. Barnett, and M. Walkiewicz Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients J Thorac Oncol 8 2013 461 468
-
(2013)
J Thorac Oncol
, vol.8
, pp. 461-468
-
-
Russell, P.A.1
Barnett, S.A.2
Walkiewicz, M.3
-
25
-
-
78751560428
-
Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma
-
H. Nakamura, A. Mochizuki, and T. Shinmyo Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma Anticancer Res 30 2010 5233 5237
-
(2010)
Anticancer Res
, vol.30
, pp. 5233-5237
-
-
Nakamura, H.1
Mochizuki, A.2
Shinmyo, T.3
-
26
-
-
84883769948
-
Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma
-
N. Tomonaga, Y. Nakamura, and H. Yamaguchi Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma Clin Lung Cancer 14 2013 521 526
-
(2013)
Clin Lung Cancer
, vol.14
, pp. 521-526
-
-
Tomonaga, N.1
Nakamura, Y.2
Yamaguchi, H.3
-
27
-
-
84883249629
-
The impact of EGFR mutation status on outcomes in patients with resected stage i non-small cell lung cancers
-
B. Izar, L. Sequist, and M. Lee The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers Ann Thorac Surg 96 2013 962 968
-
(2013)
Ann Thorac Surg
, vol.96
, pp. 962-968
-
-
Izar, B.1
Sequist, L.2
Lee, M.3
-
28
-
-
84903940270
-
Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension
-
M.W. Lin, C.T. Wu, and J.Y. Shih Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension J Surg Oncol 110 2014 99 106
-
(2014)
J Surg Oncol
, vol.110
, pp. 99-106
-
-
Lin, M.W.1
Wu, C.T.2
Shih, J.Y.3
-
29
-
-
84887550108
-
Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas
-
W.S. Liu, L.J. Zhao, and Q.S. Pang Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas Med Oncol 31 2014 771 776
-
(2014)
Med Oncol
, vol.31
, pp. 771-776
-
-
Liu, W.S.1
Zhao, L.J.2
Pang, Q.S.3
-
30
-
-
84928198468
-
Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection
-
Apr 22
-
Jeon JH, Kang CH, Kim HS, et al. Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection, Eur J Cardiothorac Surg Epub 2014 Apr 22.
-
(2014)
Eur J Cardiothorac Surg Epub
-
-
Jeon, J.H.1
Ch, K.2
Kim, H.S.3
-
31
-
-
84883378283
-
Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer
-
V.H. Lee, V.P. Tin, and T.S. Choy Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer J Thorac Oncol 8 2013 1148 1155
-
(2013)
J Thorac Oncol
, vol.8
, pp. 1148-1155
-
-
Lee, V.H.1
Tin, V.P.2
Choy, T.S.3
-
32
-
-
33746034167
-
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib
-
D.M. Jackman, B.Y. Yeap, and L.V. Sequist Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib Clin Cancer Res 12 2006 3908 3914
-
(2006)
Clin Cancer Res
, vol.12
, pp. 3908-3914
-
-
Jackman, D.M.1
Yeap, B.Y.2
Sequist, L.V.3
-
33
-
-
79954450183
-
The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients
-
J.M. Sun, Y.W. Won, and S.T. Kim The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients J Cancer Res Clin Oncol 137 2011 687 694
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, pp. 687-694
-
-
Sun, J.M.1
Won, Y.W.2
Kim, S.T.3
-
34
-
-
80054964152
-
Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations
-
Y.W. Won, J.Y. Han, and G.K. Lee Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations J Clin Pathol 64 2011 947 952
-
(2011)
J Clin Pathol
, vol.64
, pp. 947-952
-
-
Won, Y.W.1
Han, J.Y.2
Lee, G.K.3
|